BofA downgraded Universal Health (UHS) to Neutral from Buy with a price target of $223, down from $259. After the election win for Donald Trump, the firm sees risks to exchanges and Medicaid supplemental payments, noting that it views the Trump win as negative for healthcare facilities, and hospitals in particular, and believes that the current favorable environment is at risk. Trump can reduce supplemental payments administratively and the Republican president and Senate would push for enhanced subsidies expiring, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health downgraded to Neutral from Buy at BofA
- Universal Health price target raised to $285 from $275 at Wells Fargo
- Universal Health price target lowered to $275 from $283 at TD Cowen
- Universal Health price target lowered to $211 from $222 at RBC Capital
- Universal Health price target raised to $271 from $256 at Barclays